Proto Labs (PRLB) Financials

$38.39 +2.59 (+7.23%)

Closing price 03:59 PM Eastern

Extended Trading

$38.36 -0.02 (-0.07%)

As of 06:17 PM Eastern

Annual Income Statements for Proto Labs

This table shows Proto Labs' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	42	47	43	52	77	64	51	33	-103	17	17
Consolidated Net Income / (Loss)	42	47	43	52	77	64	51	33	-103	17	17
Net Income / (Loss) Continuing Operations	42	47	43	52	77	64	51	33	-103	17	17
Total Pre-Tax Income	61	68	64	74	92	81	63	40	-98	28	25
Total Operating Income	61	67	62	72	89	80	60	40	-98	28	20
Total Gross Profit	128	154	167	194	239	235	218	223	215	222	223
Total Revenue	210	264	298	344	446	459	434	488	488	504	501
Operating Revenue	210	264	298	344	446	459	434	488	488	504	501
Total Cost of Revenue	81	110	131	151	207	223	217	265	273	282	278
Operating Cost of Revenue	81	110	131	151	207	223	217	265	273	282	278
Total Operating Expenses	68	87	105	122	150	155	158	182	313	194	203
Selling, General & Admin Expense	22	30	37	41	53	50	52	56	68	66	64
Marketing Expense	29	39	46	57	69	73	69	82	83	88	92
Research & Development Expense	17	18	22	24	29	33	37	44	38	40	41
Impairment Charge	-	-	-	-	-	-	0.00	0.00	118	0.00	0.00
Restructuring Charge	-	-	-	-	-	-	-	-	6.92	0.22	5.59
Total Other Income / (Expense), net	0.00	0.71	2.45	2.21	2.76	1.34	3.11	-0.16	0.11	-0.22	4.76
Other Income / (Expense), net	0.00	0.71	2.45	2.21	2.76	1.34	3.11	-0.16	0.11	-0.22	4.76
Income Tax Expense	19	21	22	23	15	18	12	6.81	5.59	11	8.08
Basic Earnings per Share	$1.62	$1.79	$1.62	$1.94	$2.84	$2.37	$1.90	$1.21	($3.77)	$0.66	$0.66
Weighted Average Basic Shares Outstanding	25.69M	26.01M	26.37M	26.65M	26.98M	26.87M	26.74M	27.62M	27.41M	26.19M	25.10M
Diluted Earnings per Share	$1.60	$1.77	$1.61	$1.93	$2.81	$2.35	$1.89	$1.21	($3.77)	$0.66	$0.66
Weighted Average Diluted Shares Outstanding	26.10M	26.32M	26.56M	26.85M	27.28M	27.05M	26.90M	27.65M	27.41M	26.22M	25.21M
Weighted Average Basic & Diluted Shares Outstanding	25.70M	26M	26.40M	26.70M	27M	26.79M	27.60M	27.47M	26.68M	25.72M	24.23M

This table shows Proto Labs' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Income / (Loss) Attributable to Common Shareholders	3.95	-115	2.66	-0.38	7.95	6.99	5.27	4.54	7.19	-0.40
Consolidated Net Income / (Loss)	3.95	-115	2.66	-0.38	7.95	6.99	5.27	4.54	7.19	-0.40
Net Income / (Loss) Continuing Operations	3.95	-115	2.66	-0.38	7.95	6.99	5.27	4.54	7.19	-0.40
Total Pre-Tax Income	6.03	-117	5.04	2.24	11	9.94	7.73	7.36	9.87	-0.28
Total Operating Income	6.06	-117	3.75	5.61	10	8.40	6.83	6.00	8.58	-1.50
Total Gross Profit	54	49	54	53	59	56	57	57	57	52
Total Revenue	122	116	126	122	131	125	128	126	126	122
Operating Revenue	122	116	126	122	131	125	128	126	126	122
Total Cost of Revenue	68	67	72	69	71	69	70	69	68	70
Operating Cost of Revenue	68	67	72	69	71	69	70	69	68	70
Total Operating Expenses	48	166	50	48	49	47	51	51	49	53
Selling, General & Admin Expense	16	18	17	16	17	16	16	17	16	15
Marketing Expense	21	21	22	22	22	22	23	23	23	23
Research & Development Expense	9.31	8.91	11	9.87	10	9.49	11	11	9.77	9.70
Total Other Income / (Expense), net	-0.02	0.43	1.29	-3.37	0.32	1.54	0.90	1.36	1.29	1.21
Other Income / (Expense), net	-0.02	0.43	1.29	-3.37	0.32	1.54	0.90	1.36	1.29	1.21
Income Tax Expense	2.08	-1.64	2.38	2.62	2.78	2.95	2.46	2.82	2.68	0.12
Basic Earnings per Share	$0.14	($4.19)	$0.10	($0.01)	$0.31	$0.26	$0.21	$0.18	$0.29	($0.02)
Weighted Average Basic Shares Outstanding	27.51M	27.41M	26.58M	26.21M	26.02M	26.19M	25.62M	25.31M	24.98M	25.10M
Diluted Earnings per Share	$0.14	($4.19)	$0.10	($0.01)	$0.31	$0.26	$0.20	$0.18	$0.29	($0.01)
Weighted Average Diluted Shares Outstanding	27.51M	27.41M	26.61M	26.21M	26.03M	26.22M	25.78M	25.37M	25.02M	25.21M
Weighted Average Basic & Diluted Shares Outstanding	27.12M	26.68M	26.20M	26.10M	25.79M	25.72M	25.32M	25.15M	24.51M	24.23M

This table details how cash moves in and out of Proto Labs' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Net Change in Cash & Equivalents	0.29	4.32	21	-32	48	40	2.38	-62	-9.37	27	5.28
Net Cash From Operating Activities	57	64	77	82	123	116	107	55	62	73	78
Net Cash From Continuing Operating Activities	57	64	77	82	123	116	107	55	62	73	78
Net Income / (Loss) Continuing Operations	42	47	43	52	77	64	51	33	-103	17	17
Consolidated Net Income / (Loss)	42	47	43	52	77	64	51	33	-103	17	17
Depreciation Expense	11	14	17	18	27	31	33	40	39	38	36
Non-Cash Adjustments To Reconcile Net Income	0.34	5.74	5.69	8.92	9.64	11	15	19	137	20	20
Changes in Operating Assets and Liabilities, net	2.58	-3.52	10	1.52	9.58	10	8.76	-38	-11	-1.93	5.82
Net Cash From Investing Activities	-63	-64	-61	-124	-63	-44	-95	-95	-43	-4.55	-14
Net Cash From Continuing Investing Activities	-63	-64	-61	-124	-63	-44	-95	-95	-43	-4.55	-14
Purchase of Property, Plant & Equipment	-44	-44	-34	-33	-87	-62	-47	-34	-22	-28	-9.17
Purchase of Investments	-60	-66	-89	-29	-42	-50	-116	-16	-47	-1.00	-25
Sale of Property, Plant & Equipment	-	-	-	-	-	-	0.00	0.00	4.11	0.70	0.03
Sale and/or Maturity of Investments	74	52	62	48	65	68	68	83	21	24	21
Net Cash From Financing Activities	7.04	4.70	5.32	9.19	-10	-32	-11	-22	-28	-42	-59
Net Cash From Continuing Financing Activities	7.04	4.70	5.32	9.19	-10	-32	-11	-22	-28	-42	-59
Repayment of Debt	-1.05	-0.15	0.00	0.00	-5.00	0.00	-0.15	-0.56	-0.53	-0.31	-0.30
Repurchase of Common Equity	-	0.00	0.00	-4.41	-12	-34	-15	-23	-30	-44	-60
Issuance of Common Equity	4.82	6.25	5.72	8.60	8.94	4.39	7.56	5.86	3.95	3.84	4.02
Other Financing Activities, net	4.47	-	-	0.00	-2.14	-2.49	-3.44	-4.23	-1.68	-1.44	-2.00
Effect of Exchange Rate Changes	-0.46	-0.88	-0.92	0.95	-	0.05	-	-0.05	-0.44	0.37	-0.42
Cash Interest Paid	0.02	0.01	0.00	0.02	0.04	0.01	0.02	0.03	0.10	1.06	0.14
Cash Income Taxes Paid	12	20	9.80	19	9.97	4.00	5.65	7.58	19	16	14

This table details how cash moves in and out of Proto Labs' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Net Change in Cash & Equivalents	4.70	-2.80	5.49	4.44	17	0.29	9.01	3.35	-8.28	1.20
Net Cash From Operating Activities	21	11	23	9.29	24	17	21	14	25	17
Net Cash From Continuing Operating Activities	21	11	23	9.29	24	17	21	14	25	17
Net Income / (Loss) Continuing Operations	3.95	-115	2.66	-0.38	7.95	6.99	5.27	4.54	7.19	-0.40
Consolidated Net Income / (Loss)	3.95	-115	2.66	-0.38	7.95	6.99	5.27	4.54	7.19	-0.40
Depreciation Expense	9.71	9.44	9.39	9.50	9.33	9.32	9.10	8.97	8.91	8.82
Non-Cash Adjustments To Reconcile Net Income	4.78	122	3.98	7.43	4.66	4.37	4.26	4.25	4.46	6.63
Changes in Operating Assets and Liabilities, net	2.08	-6.05	6.55	-7.26	2.23	-3.45	2.70	-3.32	4.20	2.24
Net Cash From Investing Activities	-6.85	0.27	4.38	3.43	2.06	-14	4.42	-0.75	-14	-2.90
Net Cash From Continuing Investing Activities	-6.85	0.27	4.38	3.43	2.06	-14	4.42	-0.75	-14	-2.90
Purchase of Property, Plant & Equipment	-10	-5.27	-3.44	-3.39	-3.11	-18	-2.59	-4.20	-1.56	-0.83
Purchase of Investments	-6.99	-1.00	-	-	-	-1.00	-	-	-	-6.98
Sale and/or Maturity of Investments	7.30	5.66	7.63	6.39	5.10	4.75	6.98	3.44	5.29	4.92
Net Cash From Financing Activities	-7.97	-15	-22	-8.06	-9.07	-3.12	-17	-10	-19	-13
Net Cash From Continuing Financing Activities	-7.97	-15	-22	-8.06	-9.07	-3.12	-17	-10	-19	-13
Repayment of Debt	-0.14	-0.11	-0.08	-0.08	-0.07	-0.07	-0.07	-0.07	-0.07	-0.08
Repurchase of Common Equity	-7.84	-17	-21	-8.95	-8.99	-4.90	-16	-11	-19	-14
Other Financing Activities, net	-	-0.07	-0.40	0.96	-0.01	-1.99	-0.53	0.71	-	-2.17
Effect of Exchange Rate Changes	-1.01	1.54	0.13	-0.21	-0.16	0.61	-0.12	-0.05	0.41	-0.65

This table presents Proto Labs' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Total Assets	287	361	414	519	619	674	744	929	802	772	744
Total Current Assets	108	138	158	165	215	236	242	183	187	201	195
Cash & Equivalents	43	48	69	37	85	125	128	66	57	84	89
Short-Term Investments	31	33	39	57	47	35	34	12	24	19	14
Accounts Receivable	24	36	34	52	59	57	58	80	76	73	67
Inventories, net	6.19	9.77	9.31	11	10	10	11	13	14	14	12
Prepaid Expenses	3.41	5.22	5.70	6.27	8.57	8.23	11	11	13	9.12	10
Current Deferred & Refundable Income Taxes	0.00	6.03	0.45	1.83	5.76	0.00	0.54	1.32	4.04	2.23	2.91
Plant, Property, & Equipment, net	92	125	139	166	228	264	283	280	258	254	227
Total Noncurrent Assets	88	98	117	187	176	174	220	465	358	318	321
Long-Term Investments	54	65	84	37	24	13	59	14	26	8.02	18
Noncurrent Note & Lease Receivables	-	-	-	-	0.00	0.00	2.40	1.90	18	0.96	0.69
Goodwill	29	29	29	129	129	129	129	401	274	274	274
Intangible Assets	4.08	3.34	2.66	19	20	17	14	38	31	26	21
Other Noncurrent Operating Assets	0.23	0.52	0.93	2.67	3.44	14	15	9.90	8.62	9.48	7.52
Total Liabilities & Shareholders' Equity	287	361	414	519	619	674	744	929	802	772	744
Total Liabilities	21	33	34	58	77	88	100	100	105	77	73
Total Current Liabilities	19	26	23	44	53	48	50	55	72	50	53
Accounts Payable	7.88	14	11	16	17	17	18	25	17	16	16
Accrued Expenses	2.72	2.63	4.44	8.41	17	11	16	12	22	17	20
Current Employee Benefit Liabilities	6.07	9.99	7.67	12	18	15	12	14	13	15	17
Other Current Liabilities	-	-	-	-	0.00	3.34	3.82	3.85	19	1.88	1.60
Total Noncurrent Liabilities	2.73	7.13	11	14	25	40	50	45	33	27	20
Noncurrent Deferred & Payable Income Tax Liabilities	1.36	4.24	7.00	6.97	20	26	34	36	26	19	14
Other Noncurrent Operating Liabilities	1.36	2.89	3.98	4.62	4.59	14	16	9.30	6.62	8.64	6.53
Total Equity & Noncontrolling Interests	266	328	380	461	541	586	644	828	698	695	670
Total Preferred & Common Equity	266	328	380	461	541	586	644	828	698	695	670
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	266	328	380	461	541	586	644	828	698	695	670
Common Stock	181	199	214	242	259	268	285	469	474	467	454
Retained Earnings	87	134	177	225	291	325	363	377	258	256	244
Accumulated Other Comprehensive Income / (Loss)	-2.93	-5.21	-11	-5.23	-8.49	-7.02	-3.42	-17	-34	-28	-28

This table presents Proto Labs' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Period end date	9/30/2022	3/31/2023	6/30/2023	9/30/2023	3/31/2024	6/30/2024	9/30/2024
Total Assets	907	791	777	784	770	758	754
Total Current Assets	192	189	185	205	210	208	193
Cash & Equivalents	59	62	66	83	93	96	88
Short-Term Investments	25	23	20	19	17	17	13
Accounts Receivable	81	78	75	78	78	71	69
Inventories, net	15	14	14	14	13	12	12
Prepaid Expenses	12	11	8.50	8.72	9.43	10	10
Current Deferred & Refundable Income Taxes	0.76	0.82	0.87	0.89	0.64	1.40	0.67
Plant, Property, & Equipment, net	260	254	249	243	248	244	238
Total Noncurrent Assets	455	349	343	337	312	307	323
Long-Term Investments	29	20	16	12	3.26	0.00	17
Noncurrent Note & Lease Receivables	1.52	17	17	17	0.89	0.83	0.76
Goodwill	384	274	274	274	274	274	274
Intangible Assets	32	30	28	27	24	23	23
Other Noncurrent Operating Assets	8.48	8.09	7.82	7.08	9.04	8.63	8.01
Total Liabilities & Shareholders' Equity	907	791	777	784	770	758	754
Total Liabilities	96	108	95	99	82	73	74
Total Current Liabilities	61	78	66	75	58	51	54
Accounts Payable	17	20	16	18	15	16	15
Accrued Expenses	25	23	19	21	21	18	18
Current Deferred & Payable Income Tax Liabilities	0.01	1.93	0.35	1.14	3.88	-	0.99
Current Employee Benefit Liabilities	15	15	12	16	16	16	18
Other Current Liabilities	3.26	19	18	18	1.85	1.84	1.76
Total Noncurrent Liabilities	35	30	28	25	24	22	20
Noncurrent Deferred & Payable Income Tax Liabilities	27	23	21	17	16	15	13
Other Noncurrent Operating Liabilities	8.51	6.60	7.51	7.56	7.58	7.44	7.35
Total Equity & Noncontrolling Interests	811	683	683	685	687	685	680
Total Preferred & Common Equity	811	683	683	685	687	685	680
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	811	683	683	685	687	685	680
Common Stock	477	465	465	464	463	461	454
Retained Earnings	381	251	247	251	253	253	253
Accumulated Other Comprehensive Income / (Loss)	-47	-33	-29	-30	-29	-29	-27

This table displays calculated financial ratios and metrics derived from Proto Labs' official financial filings.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Period end date	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	28.49%	26.02%	12.85%	15.58%	29.35%	2.95%	-5.30%	12.36%	0.06%	3.17%	-0.59%
EBITDA Growth	20.74%	13.71%	-0.41%	13.38%	26.40%	-5.66%	-14.74%	-15.56%	-172.46%	212.02%	-7.64%
EBIT Growth	17.36%	12.11%	-5.36%	15.90%	23.13%	-11.41%	-22.47%	-36.16%	-343.57%	128.56%	-11.73%
NOPAT Growth	18.66%	10.55%	-10.76%	22.32%	47.85%	-15.72%	-22.76%	-30.71%	-304.72%	125.30%	-22.83%
Net Income Growth	18.02%	11.72%	-8.18%	21.24%	47.92%	-16.89%	-20.09%	-34.39%	-410.03%	116.64%	-3.64%
EPS Growth	17.65%	10.63%	-9.04%	19.88%	45.60%	-16.37%	-19.57%	-35.98%	-411.57%	117.51%	0.00%
Operating Cash Flow Growth	18.10%	12.04%	20.91%	5.48%	50.38%	-5.59%	-7.83%	-48.36%	12.38%	18.03%	6.22%
Free Cash Flow Firm Growth	-208.61%	105.02%	2,548.70%	-371.50%	123.75%	57.51%	1.79%	-851.94%	127.50%	-68.83%	102.55%
Invested Capital Growth	100.18%	32.52%	2.79%	79.09%	15.24%	6.75%	2.70%	74.02%	-19.76%	-1.12%	-6.02%
Revenue Q/Q Growth	6.09%	7.18%	-0.47%	6.76%	4.35%	-0.19%	-1.51%	3.91%	-1.61%	1.91%	-0.65%
EBITDA Q/Q Growth	2.73%	3.38%	-1.52%	4.99%	3.90%	-1.11%	-7.28%	3.78%	-181.19%	207.29%	-15.05%
EBIT Q/Q Growth	1.14%	3.80%	-3.35%	6.07%	2.61%	-2.64%	-11.00%	3.56%	-408.20%	128.32%	-29.29%
NOPAT Q/Q Growth	1.86%	3.13%	-5.17%	10.14%	5.95%	-4.24%	-11.47%	9.40%	-387.71%	125.46%	-34.64%
Net Income Q/Q Growth	1.68%	4.03%	-5.78%	10.45%	7.01%	-6.05%	-9.93%	7.51%	-540.02%	116.43%	-30.83%
EPS Q/Q Growth	1.27%	4.12%	-5.85%	9.66%	6.84%	-6.00%	-10.00%	8.04%	-538.37%	117.41%	-29.03%
Operating Cash Flow Q/Q Growth	6.84%	9.58%	-4.27%	4.33%	14.13%	-4.68%	-6.70%	-2.78%	-16.76%	10.09%	0.08%
Free Cash Flow Firm Q/Q Growth	7.20%	-91.51%	191.18%	-351.91%	121.96%	7.22%	-3.39%	2.63%	9.79%	-59.22%	72.65%
Invested Capital Q/Q Growth	1.28%	10.82%	-4.15%	65.86%	2.20%	0.75%	-0.45%	-0.89%	-15.19%	2.54%	-2.32%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	61.27%	58.46%	56.01%	56.27%	53.56%	51.29%	50.14%	45.62%	44.12%	44.06%	44.56%
EBITDA Margin	34.92%	31.51%	27.81%	27.28%	26.66%	24.43%	21.99%	16.53%	-11.97%	13.00%	12.07%
Operating Margin	28.88%	25.43%	20.72%	20.97%	19.95%	17.41%	13.77%	8.27%	-20.06%	5.59%	3.98%
EBIT Margin	28.88%	25.69%	21.55%	21.61%	20.57%	17.70%	14.49%	8.23%	-20.04%	5.55%	4.93%
Profit (Net Income) Margin	19.87%	17.61%	14.33%	15.03%	17.19%	13.88%	11.71%	6.84%	-21.18%	3.42%	3.31%
Tax Burden Percent	68.78%	68.54%	66.50%	69.56%	83.56%	78.40%	80.81%	83.05%	105.71%	61.61%	67.25%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Effective Tax Rate	31.22%	31.46%	33.50%	30.44%	16.44%	21.60%	19.19%	16.95%	0.00%	38.39%	32.75%
Return on Invested Capital (ROIC)	40.43%	28.83%	22.26%	19.24%	20.60%	15.69%	11.58%	5.78%	-10.33%	2.95%	2.36%
ROIC Less NNEP Spread (ROIC-NNEP)	40.43%	28.47%	21.29%	18.28%	18.96%	15.05%	10.30%	5.86%	24.82%	3.07%	-0.40%
Return on Net Nonoperating Assets (RNNOA)	-22.98%	-13.14%	-10.18%	-6.93%	-5.32%	-4.39%	-3.31%	-1.25%	-3.23%	-0.48%	0.07%
Return on Equity (ROE)	17.45%	15.68%	12.07%	12.31%	15.28%	11.29%	8.27%	4.53%	-13.56%	2.47%	2.43%
Cash Return on Invested Capital (CROIC)	-26.32%	0.85%	19.51%	-37.43%	6.44%	9.16%	8.91%	-48.25%	11.59%	4.08%	8.57%
Operating Return on Assets (OROA)	23.41%	20.94%	16.57%	15.96%	16.11%	12.56%	8.88%	4.80%	-11.31%	3.55%	3.26%
Return on Assets (ROA)	16.10%	14.35%	11.02%	11.10%	13.46%	9.85%	7.18%	3.99%	-11.96%	2.19%	2.19%
Return on Common Equity (ROCE)	17.45%	15.68%	12.07%	12.31%	15.28%	11.29%	8.27%	4.53%	-13.56%	2.47%	2.43%
Return on Equity Simple (ROE_SIMPLE)	15.68%	14.20%	11.24%	11.23%	14.14%	10.87%	7.89%	4.03%	-14.83%	2.48%	2.48%
Net Operating Profit after Tax (NOPAT)	42	46	41	50	74	63	48	34	-69	17	13
NOPAT Margin	19.86%	17.43%	13.78%	14.58%	16.67%	13.65%	11.13%	6.86%	-14.04%	3.44%	2.67%
Net Nonoperating Expense Percent (NNEP)	0.00%	0.36%	0.96%	0.96%	1.64%	0.64%	1.27%	-0.08%	-35.16%	-0.12%	2.76%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	-9.83%	2.50%	2.00%
Cost of Revenue to Revenue	38.74%	41.54%	43.99%	43.73%	46.44%	48.71%	49.86%	54.38%	55.88%	55.94%	55.44%
SG&A Expenses to Revenue	10.56%	11.25%	12.30%	11.96%	11.78%	10.85%	11.91%	11.46%	13.83%	13.06%	12.84%
R&D to Revenue	7.92%	6.95%	7.51%	6.84%	6.45%	7.13%	8.50%	9.06%	7.83%	7.97%	8.24%
Operating Expenses to Revenue	32.38%	33.04%	35.29%	35.30%	33.61%	33.88%	36.37%	37.36%	64.18%	38.47%	40.59%
Earnings before Interest and Taxes (EBIT)	61	68	64	74	92	81	63	40	-98	28	25
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	73	83	83	94	119	112	96	81	-58	65	60
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	5.09	3.57	5.95	5.64	4.64	6.37	1.71	0.99	1.44	1.43
Price to Tangible Book Value (P/TBV)	0.00	5.64	3.90	8.75	7.77	6.18	8.19	3.63	1.76	2.54	2.56
Price to Revenue (P/Rev)	0.00	6.31	4.55	7.97	6.85	5.92	9.45	2.90	1.42	1.99	1.91
Price to Earnings (P/E)	0.00	35.82	31.78	53.01	39.87	42.69	80.68	42.45	0.00	58.34	57.74
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	2.79%	3.15%	1.89%	2.51%	2.34%	1.24%	2.36%	0.00%	1.71%	1.73%
Enterprise Value to Invested Capital (EV/IC)	0.00	8.36	6.22	7.81	7.51	6.17	9.17	1.80	0.99	1.53	1.52
Enterprise Value to Revenue (EV/Rev)	0.00	5.76	3.91	7.60	6.50	5.55	8.94	2.71	1.20	1.77	1.67
Enterprise Value to EBITDA (EV/EBITDA)	0.00	18.27	14.05	27.86	24.40	22.70	40.64	16.42	0.00	13.65	13.84
Enterprise Value to EBIT (EV/EBIT)	0.00	22.41	18.13	35.18	31.62	31.33	61.69	32.97	0.00	31.98	33.93
Enterprise Value to NOPAT (EV/NOPAT)	0.00	33.04	28.35	52.12	39.01	40.63	80.30	39.54	0.00	51.51	62.52
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	23.73	15.03	32.03	23.57	21.92	36.30	23.98	9.44	12.20	10.76
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	1,119.01	32.35	0.00	124.84	69.58	104.34	0.00	7.61	37.27	17.24
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.57	-0.46	-0.48	-0.38	-0.28	-0.29	-0.32	-0.21	-0.13	-0.16	-0.17
Leverage Ratio	1.08	1.09	1.10	1.11	1.13	1.15	1.15	1.14	1.13	1.13	1.11
Compound Leverage Factor	1.08	1.09	1.10	1.11	1.13	1.15	1.15	1.14	1.13	1.13	1.11
Debt to Total Capital	0.06%	0.00%	0.00%	1.07%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.05%	0.00%	0.00%	1.07%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	99.94%	100.00%	100.00%	98.93%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	-1.75	0.00	0.00	-1.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	-3.08	0.00	0.00	-2.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	0.00	32.19	25.89	30.65	25.82	20.64	26.52	9.90	4.80	9.29	9.31
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	5.75	5.25	6.74	3.77	4.08	4.97	4.82	3.34	2.61	4.04	3.66
Quick Ratio	5.24	4.45	6.08	3.33	3.62	4.58	4.37	2.87	2.18	3.54	3.18
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-27	1.36	36	-98	23	37	37	-280	77	24	49
Operating Cash Flow to CapEx	131.50%	144.48%	230.54%	250.49%	141.13%	186.49%	227.55%	161.48%	353.16%	267.26%	851.99%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.81	0.82	0.77	0.74	0.78	0.71	0.61	0.58	0.56	0.64	0.66
Accounts Receivable Turnover	9.85	8.75	8.49	8.05	8.05	7.87	7.53	7.08	6.25	6.76	7.19
Inventory Turnover	14.29	13.74	13.74	14.64	19.38	22.16	20.69	22.10	20.41	20.70	21.39
Fixed Asset Turnover	2.84	2.43	2.25	2.25	2.26	1.87	1.59	1.73	1.82	1.97	2.08
Accounts Payable Turnover	11.32	10.19	10.50	11.08	12.43	13.06	12.36	12.17	12.78	17.09	17.83
Days Sales Outstanding (DSO)	37.05	41.70	42.97	45.33	45.32	46.39	48.45	51.57	58.40	53.99	50.77
Days Inventory Outstanding (DIO)	25.54	26.56	26.56	24.93	18.84	16.47	17.64	16.52	17.88	17.63	17.06
Days Payable Outstanding (DPO)	32.23	35.81	34.75	32.95	29.36	27.95	29.54	29.99	28.57	21.36	20.47
Cash Conversion Cycle (CCC)	30.36	32.45	34.78	37.31	34.80	34.91	36.56	38.10	47.71	50.27	47.37
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	137	182	187	335	386	412	423	737	591	584	549
Invested Capital Turnover	2.04	1.65	1.62	1.32	1.24	1.15	1.04	0.84	0.74	0.86	0.88
Increase / (Decrease) in Invested Capital	69	45	5.08	148	51	26	11	313	-146	-6.63	-35
Enterprise Value (EV)	0.00	1,521	1,165	2,618	2,898	2,544	3,883	1,325	586	894	837
Market Capitalization	0.00	1,666	1,357	2,745	3,053	2,717	4,104	1,417	692	1,005	958
Book Value per Share	$10.34	$12.52	$14.37	$17.31	$20.00	$21.89	$24.08	$30.03	$25.73	$26.96	$27.34
Tangible Book Value per Share	$9.05	$11.29	$13.18	$11.77	$14.51	$16.43	$18.74	$14.13	$14.47	$15.35	$15.29
Total Capital	266	328	380	466	541	586	644	828	698	695	670
Total Debt	0.15	0.00	0.00	5.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-128	-146	-193	-126	-155	-174	-221	-92	-107	-111	-121
Capital Expenditures (CapEx)	44	44	34	33	87	62	47	34	18	27	9.14
Debt-free, Cash-free Net Working Capital (DFCFNWC)	15	31	26	32	31	28	30	51	35	48	38
Debt-free Net Working Capital (DFNWC)	89	112	134	126	163	189	192	129	115	151	142
Net Working Capital (NWC)	89	112	134	121	163	189	192	129	115	151	142
Net Nonoperating Expense (NNE)	-0.00	-0.49	-1.63	-1.54	-2.30	-1.05	-2.51	0.13	35	0.13	-3.20
Net Nonoperating Obligations (NNO)	-128	-146	-193	-126	-155	-174	-221	-92	-107	-111	-121
Total Depreciation and Amortization (D&A)	13	15	19	20	27	31	33	40	39	38	36
Debt-free, Cash-free Net Working Capital to Revenue	7.26%	11.69%	8.75%	9.32%	6.92%	6.14%	6.92%	10.47%	7.14%	9.56%	7.68%
Debt-free Net Working Capital to Revenue	42.58%	42.31%	45.08%	36.65%	36.50%	41.17%	44.14%	26.35%	23.54%	29.96%	28.27%
Net Working Capital to Revenue	42.51%	42.31%	45.08%	35.20%	36.50%	41.17%	44.14%	26.35%	23.54%	29.96%	28.27%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.62	$1.79	$1.62	$1.94	$2.84	$2.37	$1.90	$1.21	($3.77)	$0.66	$0.66
Adjusted Weighted Average Basic Shares Outstanding	25.69M	26.01M	26.37M	26.65M	26.98M	26.87M	26.74M	27.62M	27.41M	26.19M	25.10M
Adjusted Diluted Earnings per Share	$1.60	$1.77	$1.61	$1.93	$2.81	$2.35	$1.89	$1.21	($3.77)	$0.66	$0.66
Adjusted Weighted Average Diluted Shares Outstanding	26.10M	26.32M	26.56M	26.85M	27.28M	27.05M	26.90M	27.65M	27.41M	26.22M	25.21M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	25.87M	26.20M	26.53M	26.90M	26.98M	26.79M	27.60M	27.47M	26.68M	25.72M	24.23M
Normalized Net Operating Profit after Tax (NOPAT)	42	46	41	50	74	63	48	34	19	17	17
Normalized NOPAT Margin	19.86%	17.43%	13.78%	14.58%	16.67%	13.65%	11.13%	6.86%	3.86%	3.47%	3.42%
Pre Tax Income Margin	28.88%	25.69%	21.55%	21.61%	20.57%	17.70%	14.49%	8.23%	-20.04%	5.55%	4.93%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	2.88%	3.01%	0.94%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	2.88%	3.01%	0.94%	8.52%	15.97%	52.66%	28.87%	69.76%	-28.67%	255.23%	363.27%

This table displays calculated financial ratios and metrics derived from Proto Labs' official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Period end date	9/30/2022	12/31/2022	3/31/2023	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-2.89%	-6.45%	1.36%	-3.65%	7.38%	8.17%	1.61%	2.75%	-3.89%	-2.64%
EBITDA Growth	-9.22%	-562.54%	-19.05%	-23.02%	27.47%	117.95%	16.65%	39.17%	-6.42%	-55.63%
EBIT Growth	-14.57%	-1,002.44%	-33.61%	-56.94%	77.91%	108.52%	53.32%	228.57%	-8.08%	-102.84%
NOPAT Growth	-16.35%	-782.21%	-62.65%	-137.51%	94.54%	107.20%	135.31%	485.92%	-19.00%	-117.72%
Net Income Growth	-18.28%	-1,066.12%	-47.81%	-114.98%	101.32%	106.07%	98.12%	1,285.38%	-9.62%	-105.78%
EPS Growth	-17.65%	-1,052.27%	-47.37%	-111.11%	121.43%	106.21%	100.00%	1,900.00%	-6.45%	-103.85%
Operating Cash Flow Growth	78.53%	-54.32%	26.96%	-29.93%	17.81%	63.84%	-5.49%	55.49%	2.38%	0.38%
Free Cash Flow Firm Growth	116.03%	121.09%	2,322.14%	241.97%	168.20%	-80.28%	-94.14%	-91.28%	-89.68%	172.35%
Invested Capital Growth	-6.22%	-19.76%	-20.19%	-18.39%	-18.22%	-1.12%	-0.70%	-1.31%	-1.34%	-6.02%
Revenue Q/Q Growth	-4.08%	-5.02%	8.87%	-2.86%	6.90%	-4.33%	2.27%	-1.77%	-0.01%	-3.08%
EBITDA Q/Q Growth	3.26%	-781.40%	113.45%	-18.66%	70.98%	-4.05%	-12.59%	-2.95%	14.97%	-54.51%
EBIT Q/Q Growth	15.99%	-2,034.09%	104.32%	-55.55%	379.24%	-7.42%	-22.26%	-4.74%	34.08%	-102.86%
NOPAT Q/Q Growth	55.16%	-2,167.01%	102.41%	-148.47%	904.79%	-23.48%	-21.16%	-20.51%	68.92%	-116.74%
Net Income Q/Q Growth	54.52%	-3,012.30%	102.31%	-114.40%	2,176.76%	-12.12%	-24.64%	-13.82%	58.35%	-105.62%
EPS Q/Q Growth	55.56%	-3,092.86%	102.39%	-110.00%	3,200.00%	-16.13%	-23.08%	-10.00%	61.11%	-103.45%
Operating Cash Flow Q/Q Growth	54.82%	-48.77%	114.72%	-58.86%	160.30%	-28.75%	23.86%	-32.31%	71.39%	-30.14%
Free Cash Flow Firm Q/Q Growth	32.38%	26.55%	133.31%	-12.51%	3.82%	-90.69%	-30.66%	30.10%	22.91%	145.62%
Invested Capital Q/Q Growth	-1.92%	-15.19%	-2.15%	0.26%	-1.71%	2.54%	-1.73%	-0.36%	-1.74%	-2.32%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	44.06%	42.05%	42.73%	43.45%	45.36%	44.63%	44.93%	45.01%	45.56%	42.68%
EBITDA Margin	12.93%	-92.78%	11.46%	9.60%	15.35%	15.40%	13.16%	13.00%	14.95%	7.02%
Operating Margin	4.98%	-101.32%	2.98%	4.59%	7.97%	6.71%	5.34%	4.78%	6.83%	-1.23%
EBIT Margin	4.96%	-100.95%	4.00%	1.83%	8.21%	7.95%	6.04%	5.86%	7.86%	-0.23%
Profit (Net Income) Margin	3.25%	-99.53%	2.11%	-0.31%	6.09%	5.59%	4.12%	3.61%	5.72%	-0.33%
Tax Burden Percent	65.48%	98.60%	52.77%	-17.10%	74.09%	70.34%	68.19%	61.68%	72.85%	143.26%
Interest Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Effective Tax Rate	34.52%	0.00%	47.23%	117.10%	25.91%	29.66%	31.81%	38.32%	27.15%	0.00%
Return on Invested Capital (ROIC)	2.25%	-52.18%	1.18%	-0.59%	4.61%	4.05%	3.19%	2.60%	4.43%	-0.76%
ROIC Less NNEP Spread (ROIC-NNEP)	2.26%	-18.84%	0.54%	-1.13%	4.40%	3.05%	2.63%	1.83%	3.62%	-1.31%
Return on Net Nonoperating Assets (RNNOA)	-0.27%	2.45%	-0.08%	0.16%	-0.67%	-0.48%	-0.42%	-0.29%	-0.62%	0.22%
Return on Equity (ROE)	1.98%	-49.73%	1.11%	-0.43%	3.94%	3.57%	2.78%	2.32%	3.81%	-0.54%
Cash Return on Invested Capital (CROIC)	9.73%	11.59%	11.48%	9.22%	9.28%	4.08%	4.21%	5.12%	4.97%	8.57%
Operating Return on Assets (OROA)	2.68%	-56.97%	2.27%	1.05%	4.80%	5.09%	3.92%	3.89%	5.15%	-0.15%
Return on Assets (ROA)	1.75%	-56.17%	1.20%	-0.18%	3.56%	3.58%	2.67%	2.40%	3.75%	-0.22%
Return on Common Equity (ROCE)	1.98%	-49.73%	1.11%	-0.43%	3.94%	3.57%	2.78%	2.32%	3.81%	-0.54%
Return on Equity Simple (ROE_SIMPLE)	2.90%	0.00%	-15.50%	-15.94%	-15.31%	0.00%	2.89%	3.61%	3.53%	0.00%
Net Operating Profit after Tax (NOPAT)	3.97	-82	1.98	-0.96	7.72	5.90	4.66	3.70	6.25	-1.05
NOPAT Margin	3.26%	-70.92%	1.57%	-0.78%	5.90%	4.72%	3.64%	2.95%	4.98%	-0.86%
Net Nonoperating Expense Percent (NNEP)	-0.02%	-33.34%	0.64%	0.54%	0.21%	1.00%	0.56%	0.78%	0.81%	0.55%
Return On Investment Capital (ROIC_SIMPLE)	-	-11.75%	-	-	-	0.85%	-	-	-	-0.16%
Cost of Revenue to Revenue	55.94%	57.96%	57.27%	56.55%	54.64%	55.37%	55.07%	54.99%	54.44%	57.32%
SG&A Expenses to Revenue	13.54%	15.37%	13.37%	12.94%	13.05%	12.86%	12.76%	13.21%	12.94%	12.46%
R&D to Revenue	7.65%	7.70%	8.48%	8.07%	7.73%	7.59%	8.73%	8.49%	7.78%	7.97%
Operating Expenses to Revenue	39.08%	143.36%	39.75%	38.86%	37.39%	37.92%	39.60%	40.23%	38.73%	43.90%
Earnings before Interest and Taxes (EBIT)	6.03	-117	5.04	2.24	11	9.94	7.73	7.36	9.87	-0.28
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	16	-107	14	12	20	19	17	16	19	8.54
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.24	0.99	1.29	1.34	1.01	1.44	1.34	1.14	1.09	1.43
Price to Tangible Book Value (P/TBV)	2.53	1.76	2.33	2.41	1.79	2.54	2.37	2.02	1.93	2.56
Price to Revenue (P/Rev)	2.02	1.42	1.80	1.89	1.39	1.99	1.82	1.54	1.46	1.91
Price to Earnings (P/E)	42.61	0.00	0.00	0.00	0.00	58.34	46.49	31.59	30.79	57.74
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	2.35%	0.00%	0.00%	0.00%	0.00%	1.71%	2.15%	3.17%	3.25%	1.73%
Enterprise Value to Invested Capital (EV/IC)	1.27	0.99	1.35	1.40	1.01	1.53	1.41	1.17	1.10	1.52
Enterprise Value to Revenue (EV/Rev)	1.79	1.20	1.59	1.68	1.16	1.77	1.60	1.31	1.23	1.67
Enterprise Value to EBITDA (EV/EBITDA)	12.33	0.00	0.00	0.00	0.00	13.65	11.92	9.23	8.72	13.84
Enterprise Value to EBIT (EV/EBIT)	27.96	0.00	0.00	0.00	0.00	31.98	26.40	18.71	17.80	33.93
Enterprise Value to NOPAT (EV/NOPAT)	37.25	0.00	0.00	0.00	0.00	51.51	40.00	30.55	30.31	62.52
Enterprise Value to Operating Cash Flow (EV/OCF)	11.91	9.44	11.66	12.93	8.62	12.20	11.23	8.67	7.99	10.76
Enterprise Value to Free Cash Flow (EV/FCFF)	12.67	7.61	10.42	13.67	9.76	37.27	33.35	22.68	22.07	17.24
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.12	-0.13	-0.14	-0.14	-0.15	-0.16	-0.16	-0.16	-0.17	-0.17
Leverage Ratio	1.12	1.13	1.14	1.13	1.13	1.13	1.14	1.12	1.13	1.11
Compound Leverage Factor	1.12	1.13	1.14	1.13	1.13	1.13	1.14	1.12	1.13	1.11
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	7.59	4.73	6.16	7.08	5.48	9.22	8.09	7.85	7.41	9.20
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.17	2.61	2.41	2.80	2.74	4.04	3.60	4.08	3.59	3.66
Quick Ratio	2.72	2.18	2.07	2.44	2.43	3.54	3.21	3.61	3.16	3.18
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	50	64	148	130	135	13	8.69	11	14	34
Operating Cash Flow to CapEx	286.77%	239.47%	695.35%	313.92%	796.41%	94.79%	831.89%	344.78%	1,596.00%	2,083.61%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.54	0.56	0.57	0.57	0.58	0.64	0.65	0.66	0.66	0.66
Accounts Receivable Turnover	5.97	6.25	5.99	6.16	6.22	6.76	6.51	6.98	6.82	7.19
Inventory Turnover	22.44	20.41	19.41	18.82	19.68	20.70	20.68	21.01	21.14	21.39
Fixed Asset Turnover	1.83	1.82	1.87	1.91	1.97	1.97	2.02	2.07	2.10	2.08
Accounts Payable Turnover	13.83	12.78	14.81	17.21	16.06	17.09	15.96	17.30	16.83	17.83
Days Sales Outstanding (DSO)	61.12	58.40	60.91	59.21	58.69	53.99	56.08	52.29	53.52	50.77
Days Inventory Outstanding (DIO)	16.27	17.88	18.80	19.39	18.55	17.63	17.65	17.37	17.27	17.06
Days Payable Outstanding (DPO)	26.38	28.57	24.65	21.21	22.72	21.36	22.87	21.09	21.68	20.47
Cash Conversion Cycle (CCC)	51.00	47.71	55.07	57.39	54.52	50.27	50.86	48.57	49.10	47.37
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	697	591	578	580	570	584	574	572	562	549
Invested Capital Turnover	0.69	0.74	0.75	0.75	0.78	0.86	0.88	0.88	0.89	0.88
Increase / (Decrease) in Invested Capital	-46	-146	-146	-131	-127	-6.63	-4.04	-7.61	-7.65	-35
Enterprise Value (EV)	888	586	780	813	574	894	809	669	621	837
Market Capitalization	1,002	692	884	916	689	1,005	922	782	739	958
Book Value per Share	$29.48	$25.73	$25.61	$26.05	$26.25	$26.96	$26.82	$27.07	$27.04	$27.34
Tangible Book Value per Share	$14.38	$14.47	$14.22	$14.52	$14.73	$15.35	$15.18	$15.32	$15.23	$15.29
Total Capital	811	698	683	683	685	695	687	685	680	670
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-114	-107	-105	-103	-115	-111	-113	-113	-118	-121
Capital Expenditures (CapEx)	7.16	4.39	3.25	2.96	3.04	18	2.57	4.19	1.55	0.83
Debt-free, Cash-free Net Working Capital (DFCFNWC)	47	35	25	32	27	48	42	44	39	38
Debt-free Net Working Capital (DFNWC)	132	115	110	119	130	151	152	157	139	142
Net Working Capital (NWC)	132	115	110	119	130	151	152	157	139	142
Net Nonoperating Expense (NNE)	0.02	33	-0.68	-0.58	-0.24	-1.09	-0.61	-0.84	-0.94	-0.64
Net Nonoperating Obligations (NNO)	-114	-107	-105	-103	-115	-111	-113	-113	-118	-121
Total Depreciation and Amortization (D&A)	9.71	9.44	9.39	9.50	9.33	9.32	9.10	8.97	8.91	8.82
Debt-free, Cash-free Net Working Capital to Revenue	9.47%	7.14%	5.19%	6.69%	5.50%	9.56%	8.36%	8.59%	7.70%	7.68%
Debt-free Net Working Capital to Revenue	26.52%	23.54%	22.51%	24.50%	26.27%	29.96%	30.04%	30.76%	27.63%	28.27%
Net Working Capital to Revenue	26.52%	23.54%	22.51%	24.50%	26.27%	29.96%	30.04%	30.76%	27.63%	28.27%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.14	($4.19)	$0.10	($0.01)	$0.31	$0.26	$0.21	$0.18	$0.29	($0.02)
Adjusted Weighted Average Basic Shares Outstanding	27.51M	27.41M	26.58M	26.21M	26.02M	26.19M	25.62M	25.31M	24.98M	25.10M
Adjusted Diluted Earnings per Share	$0.14	($4.19)	$0.10	($0.01)	$0.31	$0.26	$0.20	$0.18	$0.29	($0.01)
Adjusted Weighted Average Diluted Shares Outstanding	27.51M	27.41M	26.61M	26.21M	26.03M	26.22M	25.78M	25.37M	25.02M	25.21M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	27.12M	26.68M	26.20M	26.10M	25.79M	25.72M	25.32M	25.15M	24.51M	24.23M
Normalized Net Operating Profit after Tax (NOPAT)	3.97	-82	1.98	3.93	7.72	5.90	4.66	3.70	6.25	-1.05
Normalized NOPAT Margin	3.26%	-70.92%	1.57%	3.21%	5.90%	4.72%	3.64%	2.95%	4.98%	-0.86%
Pre Tax Income Margin	4.96%	-100.95%	4.00%	1.83%	8.21%	7.95%	6.04%	5.86%	7.86%	-0.23%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	99.17%	-28.67%	-47.95%	-50.06%	-53.07%	255.23%	195.90%	164.94%	212.01%	363.27%

Frequently Asked Questions About Proto Labs' Financials

When does Proto Labs's fiscal year end?

According to the most recent income statement we have on file, Proto Labs' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Proto Labs' net income changed over the last 10 years?

Proto Labs' net income appears to be on a downward trend, with a most recent value of $16.59 million in 2024, falling from $41.64 million in 2014. The previous period was $17.22 million in 2023. See Proto Labs' forecast for analyst expectations on what’s next for the company.

What is Proto Labs's operating income?

Proto Labs's total operating income in 2024 was $19.91 million, based on the following breakdown:

Total Gross Profit: $223.20 million
Total Operating Expenses: $203.29 million

How has Proto Labs revenue changed over the last 10 years?

Over the last 10 years, Proto Labs' total revenue changed from $209.58 million in 2014 to $500.89 million in 2024, a change of 139.0%.

How much debt does Proto Labs have?

Proto Labs' total liabilities were at $73.36 million at the end of 2024, a 4.8% decrease from 2023, and a 241.3% increase since 2014.

How much cash does Proto Labs have?

In the past 10 years, Proto Labs' cash and equivalents has ranged from $36.71 million in 2017 to $127.60 million in 2020, and is currently $89.07 million as of their latest financial filing in 2024.

How has Proto Labs' book value per share changed over the last 10 years?

Over the last 10 years, Proto Labs' book value per share changed from 10.34 in 2014 to 27.34 in 2024, a change of 164.6%.

Related Companies

This page (NYSE:PRLB) was last updated on 5/2/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Proto Labs (PRLB) Financials

Frequently Asked Questions About Proto Labs' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Proto Labs (PRLB) Financials

Annual Income Statements for Proto Labs

Quarterly Income Statements for Proto Labs

Annual Cash Flow Statements for Proto Labs

Quarterly Cash Flow Statements for Proto Labs

Annual Balance Sheets for Proto Labs

Quarterly Balance Sheets for Proto Labs

Annual Metrics and Ratios for Proto Labs

Quarterly Metrics and Ratios for Proto Labs

Frequently Asked Questions About Proto Labs' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools